Patent News

Reckitt, Generics Makers Settle Mucinex Antitrust Case

Reckitt, Generics Makers Settle Mucinex Antitrust Case

Reckitt Benckiser Inc. has reached a settlement with a generic-drug maker that had accused the British company of unfairly cutting out competition for an extended-release version of Mucinex by violating a patent infringement settlement agreement they’d struck, according to a judgment Tuesday ending the Pennsylvania federal court case.
Reckitt Benckiser Inc. has reached a settlement with a generic-drug maker that had accused the British company of unfairly cutting out competition for an extended-release version of Mucinex by violating a patent infringement settlement agreement they’d struck, according to a judgment Tuesday ending the Pennsylvania federal court case.

View the original article here: Reckitt, Generics Makers Settle Mucinex Antitrust Case

The article was originally posted on Law360.
Each article is copyrighted to their original authors. We do not own any rights to the news or the of the news.